Search - tctmd.com

Displaying 861 - 880 of 1143

Sort: Relevancy | Date

News Industry News

Edwards Lifesciences Receives Approval for PERIMOUNT Mitral Heart Valve in China

November 27, 2012

News Daily News

Study Explores Endovascular Treatment for Ascending Aortic Dissection

Caitlin E. Cox

November 14, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

November 04, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

Presentation TCT 2012

The Crucial and Complementary Roles of Advanced Imaging (Echo and CT) in TAVR

Presenter: Hasan Jilaihawi

October 26, 2012

News Conference News TCT 2012

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

October 26, 2012

News Conference News TCT 2012

Novel Devices for Advanced HF on Horizon

October 26, 2012

News Conference News TCT 2012

Debate Continues with the AUC

October 26, 2012

Presentation TCT 2012

Novel Device-Based Therapies for Advanced Heart Failure

Presenter: Daniel Burkhoff

October 25, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

Presentation TCT 2012

Robotic Mitral Repair: Gimmick or Major Advance?

Presenter: A. Marc Gillinov

October 24, 2012

News Conference News TCT 2012

Registries Show TAVR Evolution in UK, Internationally

October 24, 2012

Presentation TCT 2012

The Forgotten "Art" of Advanced Medical Therapy: The Case for a Conservative Approach in Managing Coronary Disease

Presenter: William Weintraub

October 24, 2012

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

October 24, 2012

News Industry News

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

October 24, 2012

Presentation TCT 2012

Advanced Directive: Treat Only Ischemia-Producing Lesions! The Mandate for Functional Guidance Before or During PCI

Presenter: Bernard De Bruyne

October 24, 2012

Advertisement

Edwards Lifesciences Receives Approval for PERIMOUNT Mitral Heart Valve in China

Study Explores Endovascular Treatment for Ascending Aortic Dissection

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

The Crucial and Complementary Roles of Advanced Imaging (Echo and CT) in TAVR

TCT Career Achievement Award Goes to CV Pathologist Renu Virmani, MD

Novel Devices for Advanced HF on Horizon

Debate Continues with the AUC

Novel Device-Based Therapies for Advanced Heart Failure

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Robotic Mitral Repair: Gimmick or Major Advance?

Registries Show TAVR Evolution in UK, Internationally

The Forgotten "Art" of Advanced Medical Therapy: The Case for a Conservative Approach in Managing Coronary Disease

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System

Elixir Medical Corporation Announces Outstanding Three-year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne® System(2)

Advanced Directive: Treat Only Ischemia-Producing Lesions! The Mandate for Functional Guidance Before or During PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content